Screening and evaluation of rat kidney aldose reductase inhibitory activity of some pyridazine derivatives

被引：0
作者：
Murat Şüküroğlu
Burcu Çalişkan-Ergün
Net Das-Evcimen
Mutlu Sarikaya
Erden Banoğlu
Sibel Suzen
机构：
[1] Gazi University,Department of Pharmaceutical Chemistry
[2] Faculty of Pharmacy,Department of Biochemistry
[3] Ankara University,Department of Pharmaceutical Chemistry
[4] Faculty of Pharmacy,undefined
[5] Ankara University,undefined
[6] Faculty of Pharmacy,undefined
来源：
Medicinal Chemistry Research | 2007年 / 15卷
关键词：
Aldose reductase; Diabetes mellitus; Inhibitory; Pyridazine; Synthesis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Aldose reductase (AR) is an enzyme that catalyzes the conversion of glucose to sorbitol, which is in turn converted to fructose by sorbitol dehydrogenase. The increased glucose flux through this metabolic pathway has been linked to the development of diabetic complications such as neuropathy, nephropathy, retinopathy, and cataract. Inhibitors of AR thus seem to have the potential to prevent or treat diabetic complications. AR inhibitors belong to different chemical classes, one of which comprises pyridazinone analogues. At present, however, side effects and/or insufficient pharmacokinetic profiles have made most of the drug candidates undesirable. We evaluated a series of 2H-pyridazine-3-one and 6-chloropyridazine analogues via an in vitro spectrophotometric assay for their ability to inhibit rat kidney AR. The study showed that the introduction of a pyrazole ring on pyridazinone led to a marked decrease in AR inhibitory potency. Moreover, introduction of an acetic acid side chain on 2H-pyridazine-3-one and 6-chloropyridazine did not improve the AR inhibitory activity, which was an unexpected result. On the basis of preliminary AR inhibitory screening results on 2H-pyridazine-3-one and 6-chloropyridazine derivatives, we embarked on the synthesis of more derivatives to discover more active molecules.
引用
收藏
页码：443 / 451
页数：8
相关论文
共 102 条
  • [1] Banoğlu E(2004)Amide derivatives of [6-(5-methyl-3-phenylpyrazol-1-yl)-3(2H)-pyrazinone-2-yl]acetic acids as potential analgesic and anti-inflammatory compounds Arch Pharm Pharm Med Chem 337 7-14
  • [2] Akoğlu C(2005)Synthesis of amide derivatives of [6-(3,5-dimethylpyrazol-1-yl)-3(2H)-pyrazinone-2-yl]acetic acid and their analgesic and anti-inflammatory properties Arzheim Forsch Drug Res 55 520-527
  • [3] Ünlü S(1976)A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 248-254
  • [4] Küpeli E(1994)Studies on the synthesis and structure-activity relationships of 5-(3′-indolyl)-2-thiohydantoin derivatives as aldose reductase enzyme ınhibitors Il Farmaco 49 443-447
  • [5] Yeşilada E(1986)Antiinflammatory and aldose reductase inhibitory activity of some tricyclic arylacetic acids J Med Chem 29 2347-2351
  • [6] Şahin MF(1996)Synthesis, activity and molecular modeling of a new series of tricyclic pyridazinones as selective aldose reductase inhibitors J Med Chem 39 4396-4405
  • [7] Banoğlu E(1999)Isoxazolo-[3,4-d]-pyridazin-7-(6 Med Res Rev 19 3-23
  • [8] Akoğlu C(1991))-one as a potential substrate for new aldose reductase inhibitors J Pharm Belg 46 375-380
  • [9] Ünlü S(1992)Synthesis and evaluation of the aldose reductase inhibitory activity of new diaryl pyridazine-3-ones Il Farmaco 47 37-46
  • [10] Çalışkan-Ergun B(2005)Synthesis and aldose reductase inhibitory activity of pyridazine derivatives possessing acetic acid group Cadiovasc Res 67 723-735
12345678910